Endocannabinoid
Resource Centre
TOP ARTICLES
Dr. Derrick DeSilva: Endocannabinoid System Clinical Uses, Dosage of Full-Spectrum Hemp Part 3 & 4
As part of our ongoing series on full-spectrum hemp, Dr. DeSilva and Today’s Practitioner’s Rob Lutz discusses the endocannabinoid system, hemp’s role as an adaptogen, what is the dosage for full-spectrum hemp?, along with many other pearls of wisdom. Click here for Part 1 & 2, Clinical Fundamentals of Full-Spectrum
Clinical Fundamentals of Full-Spectrum Hemp with Dr. Derrick DeSilva, Part 1 & 2
Full-spectrum hemp is gaining a remarkable reputation among clinicians as a fundamental and safe botanical for a variety of clinical purposes. In these short videos, Derrick DeSilva, MD and Rob Lutz, founder of Today’s Practitioner, reviews the safety, side effects and clinical uses of full-spectrum hemp (cannabidiol). What you will
Medical Cannabis Podcast with Chris Meletis, ND on Immunomodulatory & Anti-inflammatory Properties
In this podcast Micheal Ruscio, DC interviews Chris Meletis, ND on how to safely and effectively utilize cannabidiol (CBD) and medical cannabis in your practice. Most recently Dr. Meletis was featured in the Townsend Letter on a new medical certification program for practitioners prescribing CBD and other active constituents of
Early Lab Study: Hemp Shows Therapeutic Potential for Reducing Ovarian Cancer Risk
Could non-psychoactive hemp be a viable use to reduce ovarian cancer risk? As we learn more about the bioactives in hemp, the possibility becomes ever real. At the 2018 annual Experimental Biology meeting in San Diego, graduate students, Sara Biela and Chase Turner, presented the first study to examine hemp and
Beyond CBD: Exploring the Endocannabinoid System in Health and Disease, with Carl Germano PhD
Eureka! We’ve been on the search and finally found a refreshingly honest interview on the subject of the endocannabinoid system and the use of cannabidiol in clinical practice. Not surprisingly, it came from Carl Germano, PhD, RD, CNS, CDN. Germano has been in private practice in integrative and nutritional therapies
Interview with Jeffrey Chen, MD and Raphael Mechoulan, PhD on Endocannabinoids
This video, Jeffrey Chen, MD, the Director of the UCLA Cannabis Research Initiative, is the best explanation of the mechanisms and action potential of endocannabinoids in the human body. This is followed by and interview with Raphael Mechoulan, PhD, professor of Medicinal Chemistry at the Hebrew University of Jerusalem. Mechoulan
CBD Myth-Busting Study: High Doses of Cannabidiol Do Not Cause THC-Like Effects in Humans
Have you been hesitant to prescribe cannabidiol (CBD) because of concerns about gastric acids converting the CBD into psychoactive tetrahydrocannabinol (THC)? In 2016, a study by Merrick et al. suggested that when CBD is exposed to an acidic environment, it degrades to Δ9-tetrahydrocannabinol and other psychoactive cannabinoids. The following is
